26 related news articles for

Hudson Institute partner BiomeBank has secured a multimillion-dollar Federal Government grant that will turbocharge the development and production of microbiome-based therapeutics.…  Read more

Hudson Institute of Medical Research today officially unveiled its world-first RNAte platform that could see vaccines and therapeutic treatments developed faster by being able to rapidly assess their potential inflammation side effects, right here in Victoria.…  Read more

The more diverse species in your gut, the better it is for your health, but researchers have now found a way to determine which species are important and how they interact to create a healthy microbiome.…  Read more

Researchers are taking a new approach to a debilitating illness by looking for a microbiome-based cause of Inflammatory Bowel Disease (IBD).…  Read more

A new class of anti-inflammatory drug is opening a world of possibilities for treating everything from neurological diseases to cancers.…  Read more

If you have ever wondered what happens to the bacteria living in the food you eat then here is an opportunity to find out!…  Read more

When it works as intended, the human gut is rarely given a thought – but that is rare luxury for the 130,000 Australians with inflammatory bowel disease (IBD), like Marisa…  Read more

Two new candidates have been identified as crucial factors in maintaining good intestinal health.…  Read more

This is the time of year when we look back at what we have achieved and acknowledge the people who helped us make it happen. …  Read more

This inflammatory condition affecting the digestive system can seriously impact people’s lives – so what is Crohn’s disease and how is it treated?…  Read more

Hudson Institute’s Dr Samuel Forster has received a highly prestigious fellowship to advance his work using the bacteria of the human microbiome to treat Inflammatory bowel disease (IBD).…  Read more

A naturally occurring molecule found in soy products could hold the clue to a new class of potent anti-inflammatory drugs, targeting diseases ranging from heart conditions to COVID-19.…  Read more

Bacteria that cause weight loss and intestinal inflammation have been identified in the microbiome of mice used to study Inflammatory Bowel Disease (IBD).…  Read more

Many human diseases, including autoimmune diseases such as arthritis or inflammatory bowel disease, are characterised by too much inflammation.
There has been a gap in producing new generations of potent anti-inflammatory therapeutics for these anti-inflammatory conditions.…  Read more

Hudson Institute of Medical Research is progressing its genomic and inflammation research with the acquisition of an Illumina NextSeq 2000, a new sequencing system that provides unprecedented genomic capacity to study inflammatory diseases and microbial diversity.…  Read more

Rachel Botros has suffered from Crohn’s disease since she was a 14-year-old. The chronic condition interrupted her schooling and ability to live a typical teenage life. Her two siblings also have the disease. …  Read more

Crohn’s is an inflammatory disease which affects the gastrointestinal tract. It is incurable and usually chronic with periods of flare ups lasting from anywhere from a few days to a several months.…  Read more

Hudson Institute has been successful in the NHMRC Ideas Grant round. Our researchers have been awarded four NHMRC Ideas Grants, totalling almost $4.1 million.…  Read more

Crohn’s disease is an incurable inflammatory bowel disease (IBD) affecting more than 60,000 Australians, including children.…  Read more

Hudson Institute researchers provide new insights into how the IL-37 protein blocks inflammation—emphasising the potential for a novel treatment in the fight against a plethora of inflammatory diseases.…  Read more

Hudson Institute has had outstanding success in the NHMRC Ideas Grant round.

Our researchers have been awarded nine NHMRC Ideas Grants, totalling almost $8.5 million and a success rate of 19.1 per cent.…  Read more

Scientists working on the gut microbiome have discovered and isolated more than 100 completely new species of bacteria from healthy people’s intestines.…  Read more

Hudson Institute has had outstanding success in the recent National Health and Medical Research Council (NHMRC) Fellowship and Development Grant announcements.…  Read more

Hudson Institute has had outstanding success in the recent NHMRC Project Grant round. In addition, our researchers have been awarded an NHMRC Partnership Grant, an NHMRC Development Grant, an ARC Discovery Grant and three NMHRC Fellowships.…  Read more

Dr Jaclyn Pearson from the Centre for Innate Immunity and Infectious Diseases has been named as a L’Oréal-UNESCO For Women in Science 2017 Australian Fellow. The prestigious fellowship recognises Dr Pearson’s contribution to science and will support her career progression. Read about what has inspired Dr Pearson and her work.…  Read more

Researchers are optimistic that a recent breakthrough allowing growth of the majority of human gut bacteria in the lab will lead to the development of new therapies for human health, replacing the use of faecal transplants in treating certain gut infections.…  Read more